Vas Deferens, Congenital Bilateral Aplasia of

Alternative Names

  • CBAVD
  • CAVD
Back to search Result
WHO-ICD-10 version:2010

Congenital malformations, deformations and chromosomal abnormalities

Congenital malformations of genital organs

OMIM Number

277180

Mode of Inheritance

Autosomal recessive

Gene Map Locus

7q31.2

Description

The vas deferens is a tube-like structure in the male reproductive system that connects the epididymis, the site of storage of sperm, to the urethra, the tube that expels the sperm. Congenital absence of the vas deferens (CAVD) is a condition where the vas deferens fails to develop normally, resulting in defects in the absence of transport of the sperm to the urethra. The condition can be unilateral or bilateral; in the latter case, leading to azoospermia and infertility. From 65-90% of patients affected by this condition are carriers of cystic fibrosis, and mutations in the CFTR gene in these patients are actually causal of CBAVD. In fact, CBAVD is one of the most consistent features of CF. In most patients with CAVD, the body and tail of the epididymis also may be absent; however, the head is invariably present. Spermatogenesis is usually normal, even though sperms cannot be detected in the semen.

About 2% of men with infertility are supposed to suffer from CBAVD. Semen in affected individuals contains little or no sperms, and is usually acidic and low in volume. Since spermatogenesis is normal, infertility can be treated in such patients with the use of techniques like microsurgical epididymal sperm aspiration (MESA) and intracytoplasmic sperm injection (ICSI). However, considering the risk of having progenies affected with CF, it is important before such a procedure to undergo genetic counseling and preferably to get the carrier status of the female partner checked out.

Molecular Genetics

Mutations in the CTFR gene are responsible for the condition in a large majority of cases of CBAVD. About 50-83% of CAVD patients have at least one known CFTR mutation, while about 10% have two known CFTR mutations. In men with two mutations, one is usually mild. The most common of these mutations is D508, followed by 5T, R117H, R75Q, G542X, N1303, W1282X, G551A, and R347H.

Epidemiology in the Arab World

View Map
Subject IDCountrySexFamily HistoryParental ConsanguinityHPO TermsVariantZygosityMode of InheritanceReferenceRemarks
277180.1KuwaitMale Absent vas deferensNM_000492.4:c.1520_1522del, NM_000492.3:c.1210-12=, NM_000492.4:c.1210-7_1210-6dupHeterozygousAutosomal, RecessiveLissens et al. 1999
277180.2KuwaitMale Absent vas deferens; Pelvic kidneyNM_000492.4:c.1622T>CHomozygousAutosomal, RecessiveLissens et al. 1999
277180.3EgyptMale Absent vas deferensNM_000492.3:c.1210-12=, NM_000492.4:c.1210-7_1210-6dupHeterozygousAutosomal, RecessiveLissens et al. 1999
277180.4EgyptMale Absent vas deferensNM_000492.4:c.1210-7_1210-6del, NM_000492.4:c.1210-7_1210-6dupHeterozygousAutosomal, RecessiveLissens et al. 1999
277180.5TunisiaMale Absent vas deferensNM_000492.4:c.601G>AHeterozygousAutosomal, RecessiveMessaoud et al. 2005
277180.G.1.1KuwaitMale Absent vas deferensNM_000492.4:c.1520_1522delAutosomal, RecessiveSamilchuk, 2005 Unknown number of pa...
277180.G.1.2KuwaitMale Absent vas deferensNM_000492.4:c.1210-7_1210-6delAutosomal, RecessiveSamilchuk, 2005 Unknown number of pa...
277180.G.2.1EgyptMale Absent vas deferensNM_000492.3:c.1210-12=HomozygousAutosomal, RecessiveLissens et al. 1999 5 patients with CBAV...
277180.G.2.2EgyptMale Absent vas deferens; Abnormality of the ...NM_000492.3:c.1210-12=HomozygousAutosomal, RecessiveLissens et al. 1999 3 patients with CBAV...
277180.G.2.3EgyptMale Absent vas deferensNM_000492.4:c.1210-7_1210-6delHomozygousAutosomal, RecessiveLissens et al. 1999 5 patients with CBAV...
277180.G.2.4EgyptMale Absent vas deferensNM_000492.3:c.1210-12=, NM_000492.4:c.1210-7_1210-6delHeterozygousAutosomal, RecessiveLissens et al. 1999 3 patients with CBAV...
277180.G.3.1EgyptMale Absent vas deferensNM_000492.4:c.1520_1522delHeterozygousAutosomal, RecessiveHussein et al. 2011 12 out of 30 patient...
277180.G.3.2EgyptMale Absent vas deferensNM_000492.3:c.1210-12=HomozygousAutosomal, RecessiveHussein et al. 2011 3 out of 30 patients...
277180.G.3.3EgyptMale Absent vas deferensNM_000492.4:c.1210-7_1210-6delHomozygousAutosomal, RecessiveHussein et al. 2011 2 out of 30 patients...
277180.G.3.4EgyptMale Absent vas deferensNM_000492.4:c.1210-7_1210-6dupHomozygousAutosomal, RecessiveHussein et al. 2011 3 out of 30 patients...
277180.G.3.5EgyptMale Absent vas deferensNM_000492.3:c.1210-12=, NM_000492.4:c.1210-7_1210-6dupHeterozygousAutosomal, RecessiveHussein et al. 2011 10 out of 30 patient...
277180.G.3.6EgyptMale Absent vas deferensNM_000492.3:c.1210-12=, NM_000492.4:c.1210-7_1210-6delHeterozygousAutosomal, RecessiveHussein et al. 2011 6 out of 30 patients...
277180.G.3.7EgyptMale Absent vas deferensNM_000492.4:c.1210-7_1210-6del, NM_000492.4:c.1210-7_1210-6dupHeterozygousAutosomal, RecessiveHussein et al. 2011 6 out of 30 patients...
© CAGS 2024. All rights reserved.